+13.1%
GSK vs MSTZ
-63.1%
+76.2%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MSTZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | -9.6% | +14.6% | +5.0% |
| 7D | +4.9% | +0.7% | +4.2% | +4.9% |
| 30D | +9.9% | +16.6% | -6.7% | +9.9% |
| 3M | +0.2% | -74.7% | +74.8% | -0.4% |
| 6M | +2.3% | -43.9% | +46.2% | +2.0% |
| YTD | +7.1% | -84.0% | +91.1% | +6.3% |
| 1Y | +13.1% | -65.1% | +78.2% | +14.4% |
| All | +13.1% | -63.1% | +76.2% | +14.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MSTZ.
Daily Out/Under-Performance
Portfolio return minus MSTZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MSTZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MSTZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling